Shenzhen Yhlo Biotech (688575.SH) Obtains Medical Device Registration Certificate

Stock News11-06

Shenzhen Yhlo Biotech Co., Ltd. (688575.SH) announced that it recently received a medical device registration certificate issued by the National Medical Products Administration. The product, named "Human Chorionic Gonadotropin and β-Subunit Assay Kit (Chemiluminescence Method)," is designed for the quantitative in vitro determination of human chorionic gonadotropin and β-subunit levels in human serum and/or plasma.

This kit is primarily used for dynamic monitoring of malignant tumor patients to assist in evaluating disease progression or treatment efficacy. However, it cannot serve as a basis for early diagnosis or confirmation of malignant tumors and is not intended for cancer screening in the general population.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment